Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Biovica International AB (publ)
  6. News
  7. All News
    BIOVIC B   SE0008613731

BIOVICA INTERNATIONAL AB (PUBL)

(BIOVIC B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about BIOVICA INTERNATIONAL AB (PUBL)
06/17BIOVICA INTERNATIONALá : Year-end Report February-April 2020/2021
AQ
06/11BIOVICA INTERNATIONALá : - Premium potential
AQ
05/22BIOVICA INTERNATIONALá : Capital Markets Day invitation June 9
AQ
05/20BIOVICA INTERNATIONALá : DiviTumTKa shows strong capabilities in malignant melan..
AQ
04/29BIOVICA INTERNATIONALá : strengthens the management team
AQ
04/23BIOVICA INTERNATIONALá : DiviTum«TKa budget impact model results show potential ..
AQ
03/18BIOVICA INTERNATIONALá : Q3 Interim report November-January 2020/2021
AQ
03/11BIOVICA INTERNATIONALá : DiviTumTKa prognostic for long-term outcome
AQ
02/26BIOVICA INTERNATIONALá : Nomination Committee for Biovica for the 2021 Annual Ge..
AQ
01/29BIOVICA INTERNATIONALá : FDA resumes review of DiviTum«TKa submission
AQ
01/18BIOVICA INTERNATIONALá : DiviTum«TKa in early treatment resistance trial
AQ
01/16BIOVICA INTERNATIONALá : FDA resource reallocation continues to impact DiviTum«T..
AQ
01/12BIOVICA INTERNATIONALá : CEO and main shareholder lends shares for redemption of..
AQ
2020BIOVICA INTERNATIONALá : Q2 Interim Report August-October 2020/2021
AQ
2020BIOVICA INTERNATIONALá : DiviTum«TKa included in new UK breast cancer study
AQ
2020BIOVICA INTERNATIONALá : Multicenter study PYTHIA presents positive DiviTum«TKa ..
AQ
2020BIOVICA INTERNATIONALá : CDK 4/6 dosing study supports DiviTum«TKa as an early a..
AQ
2020BIOVICA INTERNATIONALá : announces initial results in clinical genomics study of..
AQ
2020BIOVICA INTERNATIONALá : DiviTum«TKa Monitoring Capabilities Confirmed in SWOG S..
AQ
2020BIOVICA INTERNATIONALá : FDA submission will proceed to substantive review
AQ
2020BIOVICA INTERNATIONALá : FDA resource reallocation impacts DiviTum«TKa timeline
AQ
2020BIOVICA INTERNATIONALá : DiviTum«TKa in four posters at SABCS
AQ
2020BIOVICA INTERNATIONALá : completes 510(k) submission for DiviTum«TKa to the FDA
AQ
2020BIOVICA INTERNATIONALá : Bulletin from the annual general meeting in Biovica
AQ
2020BIOVICA Q1 INTERIM REPORT : May-July 2020/2021
AQ
2020BIOVICA INTERNATIONALá : carries out a directed share issue of Class B shares an..
AQ
2020BIOVICA INTERNATIONALá : intends to carry out a directed share issue of Class B ..
AQ
2020BIOVICA INTERNATIONALá : successfully completes clinical validation for DiviTum«..
AQ
2020BIOVICA INTERNATIONAL PUBLá : Notice to AGM for Biovica International AB
AQ
2020BIOVICA INTERNATIONAL ABá : – Annual Report for the fiscal year 2019/2020 ..
AQ
2020BIOVICA INTERNATIONAL PUBLá : completes analytical validation as part of FDA app..
AQ
2020Biovica Year-end Report for 2019/2020
AQ
2020BIOVICA INTERNATIONAL PUBLá : DiviTum« acknowledged in ASCO educational book
AQ
2020BIOVICA INTERNATIONAL PUBLá : DiviTum« and TK activity acknowledged in highly re..
AQ
2020BIOVICA INTERNATIONAL PUBLá : provides market share target at today's Capital Ma..
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020REMINDER : Biovica invites to virtual Capital Markets Day 11 May
AQ
2020BIOVICA INTERNATIONAL PUBLá : invites to virtual Capital Markets Day 11 May
AQ
2020BIOVICA INTERNATIONAL PUBLá : initiates a collaboration with Mayo Clinic to stud..
AQ
2020BIOVICA INTERNATIONAL PUBLá : strengthens its commercial leadership
AQ
2020BIOVICA INTERNATIONAL PUBLá : DiviTumá-áfirst study published on CDK4/6 inhibito..
AQ
2020BIOVICA INTERNATIONAL PUBLá : provides updates on FDA application
AQ
2020BIOVICA INTERNATIONAL PUBLá : Clinical Cancer Research publishes results support..
AQ
2019BIOVICA INTERNATIONAL PUBLá : strengthens management team
AQ
2019Q2 INTERIM REPORT : Work with the FDA application progressing as planned
PU
2019Q2 INTERIM REPORT : áWork with the FDA application progressing as planned
AQ
2019BIOVICA INTERNATIONAL PUBLá : DiviTum validated as a dynamic biomarker in metast..
PU
2019BIOVICA INTERNATIONAL PUBLá : DiviTum - Strong prognostic marker in operable bre..
AQ
2019BIOVICA INTERNATIONAL PUBLá : DiviTum validated as a dynamic biomarker in metast..
AQ